Editorial: Arterial Stiffness, Central Haemodynamics and Non-Alcoholic Fatty Liver Disease: Links with Cardiovascular Risk and Effects of Drug Treatment

Title:Editorial: Arterial Stiffness, Central Haemodynamics and Non-Alcoholic Fatty Liver Disease: Links with Cardiovascular Risk and Effects of Drug Treatment

Volume: 16 Issue: 4

Author(s): Niki Katsiki, Konstantinos Imprialos and Charalambos Vlachopoulos*

Affiliation:

• First Department of Cardiology, National and Kapodistrian University of Athens, Hippokration Hospital, Athens,Greece

Keywords: Arterial stiffness, central haemodynamics, non-alcoholic fatty liver disease, cardiovascular risk, antihypertensive, hypolipidaemic drugs, antidiabetic drugs.

Abstract: Arterial stiffness, central haemodynamics and Non-Alcoholic Fatty Liver Disease (NAFLD) have been associated with increased risk for Cardiovascular (CV) morbidity and mortality. Antihypertensive, antidiabetic and hypolipidaemic drugs may affect these predictors of CV risk. Such associations should be taken into consideration when treating high-risk patients.

Cite this article as:

Katsiki Niki, Imprialos Konstantinos and Vlachopoulos Charalambos *, Editorial: Arterial Stiffness, Central Haemodynamics and Non-Alcoholic Fatty Liver Disease: Links with Cardiovascular Risk and Effects of Drug Treatment, Current Vascular Pharmacology 2018; 16 (4) . https://dx.doi.org/10.2174/1570161116666171205105402